chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 8/30/2021 I got a Covid Booster (Moderna). On 9/10/2021 I got my first Shingles Vaccine -recombinant- and an Influenza vaccine. On  9/27/2021 I traveled to another country and on 9/29/2021 I started to get symptoms of a viral infection (cold with body aches and sniffles). I started to feel quite dizzy at that time, but it was bearable, I thought it was possibly from taking so much cold medicine. I had done a number of self-covid tests and 2 lab tests to check for Covid, and they were all negative. On 10/5/2021 the dizziness became so intense that I could not even stand up. I called an ambulance and was admitted to the hospital, eventually diagnosed with Vestibular Neuritis. The ENT thought that my system had had viral overload and the Vestibular Neuritis was caused by a virus. For 3 days, I could not move my head, body, open my eyes, eat, and I was throwing up and had extreme shaking. I do not believe it was directly related to the Moderna vaccine, but what I do believe is that I had too many vaccines in a short amount of time and was susceptible to infections & that my immune system could not keep up. I was especially sick after I got the shingles and flu vaccines on 9/10. I had strong flu like symptoms, but they cleared up in 48 hours. The shingles vaccine pain did last about 10 days at the site of the shot in my arm.
some pain at left upper arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (some pain at left upper arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (some pain at left upper arm). At the time of the report, PAIN IN EXTREMITY (some pain at left upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter.
Patient received first dose of Pfizer vaccine and waited her required 15 min observation time. About 5 min after her injection she felt dizzy and lightheaded. RN assessed pt and gave her water, had her put her head back and legs up. After a few minutes she was feeling better until she started complaining of nausea and abdominal cramps. Her pulse was thready but pt was awake and alert, responding to questions. Patient elected to go to the ER via ambulance.
Patient presented to the ER with rapid and irregular heartrate. Patient was admitted to the ICU for continued evaluation and observation. He was diagnosed with new onset A-fib with RVR. Patient is being discharged with normal sinus rhythm.
This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Have not received the vaccine in the 42 days window) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Have not received the vaccine in the 42 days window). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Have not received the vaccine in the 42 days window) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up received on 07-Jun-2021 included no new information.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: Not provided) with no associated AEs.
Pt received vaccine around 11:00 am this morning. Pt waited the 15 minutes outside with his coworkers. On the way home, pt started not feeling well and turned around and came back to  office. Pt reporting dizzy/lightheaded, nauseous, blurred vision, and chills. Pt was taken to back of office and laid down on floor with his feet elevated. Fan placed on pt. Series of vital signs taken. Pt denied shortness of breath or swelling of throat. Pt's eyes dilated. Eyes were equal, round, and reactive to light bilaterally. Neuro intact. Pt alert and orientated x4. 12:09- BP: 152/83  HR: 91  O2: 99% room air. 12:14- BP: 146/77  HR: 90  O2: 100% room air- Ambulance called 12:17- BP: 145/83   12:20- BP: 148/81 HR: 91  O2: 100% room air 12:27 BP: 142/83  HR: 93  O2: 99% room air pt sat up  12:30  BP: 136/85  HR: 98  O2: 98% room air pt sat up in chair 12:34  BP: 126/80  HR: 92 O2: 100% room air pt stood up 12:37 BP: 126/85  HR: 95  O2: 100% room air pt left facility escorted by this nurse was consulted, and suggested  pt go to ER via ambulance. Pt refused ambulance. Pt's employer called to give update per Pt's consent. Pt drove home by coworkers and strongly recommended to go home and rest.
ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/18/2022 PNEUMONIA
Lower back pain radiating tothe testicle area; Body Aches; Fever; Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain radiating tothe testicle area), PAIN (Body Aches), PYREXIA (Fever) and MYALGIA (Myalgia) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PAIN (Body Aches), PYREXIA (Fever) and MYALGIA (Myalgia). On 14-Apr-2021, the patient experienced BACK PAIN (Lower back pain radiating tothe testicle area). At the time of the report, BACK PAIN (Lower back pain radiating tothe testicle area), PAIN (Body Aches), PYREXIA (Fever) and MYALGIA (Myalgia) outcome was unknown.            patient was treated with Advil.
The day after pt received vaccination, she c/o redness, swelling, and pain of upper right arm. Pt also reported headache, fatigue, nausea, loss of appetite and fever.  Pt took 1,000 mg of Tylenol every 6 hours for 3 days after vaccine. She was seen in clinic on 7/29/19 and prescribed clobetasol 0.05% topical cream BID and ondansetron 8 mg sublingual tablet for nausea.
throat swelling; This case was reported by a physician via sales rep and described the occurrence of throat swelling in a adult patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2019-2020 season) (batch number GD44Z, expiry date 30th June 2020) for prophylaxis.   On 1st October 2019, the patient received FluLaval Tetra 2019-2020 season. In October 2019, less than a week after receiving FluLaval Tetra 2019-2020 season, the patient experienced throat swelling. On an unknown date, the outcome of the throat swelling was recovered/resolved.   It was unknown if the reporter considered the throat swelling to be related to FluLaval Tetra 2019-2020 season.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that a patient after receiving the Flulaval vaccine 2019-2020, the patient had a throat swelling. There was no hospitalization.  Additional information was not provided.   The patient identifiers were not available. The reporter consented to follow up.
Patient receive vaccine at 1005 and went home. Contacted clinic by phone 1114 stating her was shaking and cold and has bad leg cramps. He then developed r) arm numbness. He came back to the clinic immediately. Pale and had severe trembling upon arriving.  Patient was seen by provider within 2 min. Benadryl ordered but was not given as patient started to feel better before we had time to administer that. Shaking and arm numbness resolved on its own within 5 min of being at the clinic but he vomited and felt tired. Ok by provider to go home and monitor
This case was reported by a healthcare professional and described the occurrence of arm swelling (injection site) in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Previous and/or concomitant vaccination included MMR (strain not specified), rubella vaccine; manufacturer unspecified given on the same unspecified date as KINRIX; measles and varicella virus vaccine; manufacturer unspecified given on the same unspecified date as KINRIX. On an unspecified date the subject received 1st dose of KINRIX (unknown). At an unspecified time after vaccination with KINRIX, the subject experienced arm swelling (injection site). A sales representative reported that a public health nurse stated that she gave ten doses of KINRIX and out of these doses, seven children or their parents reported significant swelling in the arm where they were injected. All of the children were within the four to six years age range. She stated that she gave KINRIX on one arm and a MMR vaccine and Varicella vaccine on the other arm. Please see A0780868A, A0780875A, A0780876A, A0780877A, A0780878A and A0780880A for the six additional cases reported by the nurse. At the time of reporting the event was resolved. The healthcare professional considered the event was probably related to vaccination with KINRIX.
Coughing 10:00PM, 09/18/2013 6:00 AM swollen eyes and lips. No treatment, symptoms subsided by 5:30 PM 09/18/2013.
Nine children were evaluated after experiencing an allergic reaction to the first dose; This is a literature report.  An 8-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANAPHYLACTIC REACTION (medically significant), 10 min after the suspect product administration, outcome "recovered", described as "Nine children were evaluated after experiencing an allergic reaction to the first dose". The patient underwent the following laboratory tests and procedures: Brighton score: 2. Therapeutic measures were taken as a result of anaphylactic reaction. Additional information: Age: 8; Sex: M; Atopic history: No; Anaphylaxis cause: No; Onset after receipt, min: 10; Signs and symptom: Throat hurt, closing up, dry heaving, gagging, nausea, difficulty breathing; Intervention: Epinephrine, diphenhydramine, famotidine, steroids; Time to symptoms resolution, h: Several; Meet Resource criteria: Yes; Brighton score: 2; Symptoms after second dose: None.; Sender's Comments: Based on the information provided there is a reasonable possibility of causal association between the event anaphylaxis with the suspect product.,Linked Report(s) : US-PFIZER INC-PV202300015137 Same article/ drug and different patient/ event;
Patient had seizure like activity 5 minutes after vaccine was injected. Turned pale white, body stiffened, convulsed, foamed at mouth, regained consciousness 2 times in and out before finally coming all the way back to consciousness. Patient woke up tearful and confused. Was disoriented and very tired/ weak for about 2 hours after injection.
Headache (migraine type for 10 days), double dose of Advil and Tylenol 4-5 times a day.  Headache subsided after 10 days. Blood pressure dropped by 60 points (typically I have high blood pressure 140/110, it dropped to 80/60) on the first night after injection. light headed the first night.
10/5 started w/ nausea and patient recovered quickly. Overnight pt experienced muscle soreness and that is now gone.  Pt then started experiencing tingling in the legs.  She states that it has diminished, but is not completely gone when she called on 10/22. I advised patient to call physician.
extreme burning & itching, extensive swelling elbow to neck, pounding headache, muscle pain, joint pain, low fever, nauseous.  Treatment:  tylenol, benedryl, ice, naproxen. symptoms subsided somewhat after 3 days. at 5 days can use arm.  At 7 days still headache and itching, continue with tylenol, applying Lanacane As of this date, 8/24/09, the injection site continues to throb and is painful to the touch.  I also continue to have muscle cramping and headaches.
Vertigo; Dizziness; Nausea; Diarrhea; Fatigue; This case was reported by a nurse via call center representative and described the occurrence of fatigue in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th September 2019, the patient received Shingrix. On 15th September 2019, 1 days after receiving Shingrix, the patient experienced fatigue. On 16th September 2019, the patient experienced vertigo, dizziness, nausea and diarrhea. On an unknown date, the outcome of the fatigue, vertigo, dizziness, nausea and diarrhea were recovering/resolving.   It was unknown if the reporter considered the fatigue, vertigo, dizziness, nausea and diarrhea to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient experienced fatigue, vertigo, dizziness, nausea and diarrhea. The reporter stated that, the events were much better at the time of reporting. No further information was provided at the time of reporting regarding vaccine and events. The reporter consented to follow up.
Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Medium, Systemic: Visual Changes/Disturbances-Medium, Systemic: Vomiting-Medium
fever @ site, swollen rt arm;rt shoulder to elbow swollen;30APR97 mom reported that everything is okay now, did not see a MD for the above complaints;
This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Hives (Patient was prone to hives several months before receiving vaccine.). On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Concomitant product use was not provided by the reporter. The patient went to seek medical advice from her allergist and decided to receive the second dose and the hives worsened after the second dose, patient went to emergency room on 14 Feb 2021. The doctor wanted to administer the steroid. No treatment information was provided.
I got my second Pfizer booster for COVID-19 on 4/6/2022. On 5/20/2022, I caught a virus, but it was not COVID-19. I then developed a secondary bacterial sinus infection with bronchitis. Over the holiday, I went to an urgent care clinic, and the NP prescribed doxycycline (6-day course), benzonatate (to use as needed), and an albuterol inhaler. The symptoms improved while I was on the doxycycline. However, about 3 days after the last doxycycline pill, the sinus infection and cough reappeared. On 6/14/2022, I had a telehealth appointment with my PCP. He told me I needed a stronger antibiotic to take for a longer period of time, so he prescribed Augmentin (875 mg), which I was to take twice a day for 10 days. I then began to feel better for a while. On 6/25/2022, I went on a trip abroad. While I was on vacation, I began to feel worse. I had the same symptoms as I did previously.  On 6/28/2022, I also developed chills, rigors, fever, and sweats, which I had never had before with the aforementioned current illnesses. I called my doctor while I was on vacation, and he recommended that I see an otolaryngologist, because there was nothing else he could do for me. I then called my ENT and arranged for an appointment on 7/5/2022. It was around this time that my ears became clogged; at the time of this writing, I have a great deal of difficulty hearing. On 6/30/2022, we returned home from vacation. On 7/1/2022, my husband took an at-home test for COVID-19, and the result was positive. Within 15 minutes after he got his result, I also took an at-home test and also got a positive result. On account of my COVID-19-positive status, my appointment with the ENT has had be rescheduled for 7/14/2022. Since I was unable to see a doctor for the treatment of my sinus infection, bronchitis, ear congestion, and COVID-19, I ended up going to the ER on 7/3/2022. At the ER, a chest X-ray was performed, and my lungs were clear.  An EKG was also performed, and the results were normal. I explained my situation to the ER doctor, and I was prescribed another 10-day course of Augmentin. I was also given dexamethasone, which has really helped clear my sinus passages. As a result, my coughs and my nose blowing are now more productive. However, I still do have the sinus infection, ear congestion, a deep cough, and chest congestion. On 7/6/2022, I woke up with conjunctivitis in both eyes, with the right eye being the more affected. I called my PCP, and he prescribed me ciprofloxacin. I have at this point only used it a few times, but I am seeing improvement. However, the mucus I expel maintains a greenish color with pus. My ear congestion and loss of hearing still persists. My sense of smell at the time of this writing is tenuous. I have lost 12 lbs. since 5/20/2022, because I've lost much of my appetite. I'm also very fatigued; I'm normally a very active and energetic person, but at this point, I usually have to rest frequently throughout the day. I've also been sleeping 12 hours at night, but whenever I get out of bed, I can easily migrate to the sofa and doze off again.
It was reported that a pt (5 of 9) received a Tripedia vaccination the week of 3/23/01. Reportedly, sometime after the vaccination (date not specified), the pt developed a large local reaction at the injection site. From additional correspondence received on 5/16/01, additional pt, vaccine administrator and responsible physician information was provided.
Patient was administered the Moderna Covid-19 Vaccine at age 17 in error, not approved for under 18. Patient had NO adverse outcomes, this is a report of a medication error.
My father died, 20 days after his 2nd vaccination. Not sure if it is related to the vaccine, but a sister reported Arthritis pain, 3 times as bad, after the 2nd vaccination and recommended I report this. My father started having severe back pain, 3 days after the second immunization. I took him for an XRay and the hospital said he had Compression Fractures of the vertebrae, but they could not tell if they were new or old, so needed to do an MRI. Said it also looked like he had a Bowel Obstruction, but I told them he had been having normal BM's up to the previous day. He lived until the 17th of April and never had another BM. They said bring him to the ER. The ER decided to do a CAT Scan, but Dad was not interested in any further treatment. He just wanted to go, so we put him on palliative care and he passed away, 20 days after the 2nd vaccination.
Blood clots; This is a spontaneous report from a contactable consumer (reported for herself). A 65-years-old (non-pregnant) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EN6199, expiry date not reported),  via an unspecified route of administration, administered in left arm on 03Mar2021 10:45 at a single dose for covid-19 immunisation. Medical history included known allergies to sulpha. The patient had no Covid prior vaccination. Concomitant medications included atorvastatin (LIPITOR) and lisinopril, both taken for an unspecified indication, start and stop date were not reported. The patient had no other vaccine in four weeks. The patient had the vaccination on a public health clinic/veterans administration facility. On 12Mar2021, patient experienced blood clots that resulted in doctor other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient was not tested for Covid post vaccination. Therapeutic measures were taken as result of the event which included that the patient was put on blood thinners. The event blood clots recovered with lasting effects.
Headache off and on up until 25 hours, tingling sensation down left arm which was injection arm, tingling down leg and arm around 11:30 pm, chills that would last a few minutes at a time at 11:35pm, red eyes around 8pm until the next morning, extremely thirsty 3 hours after dose till 30 hours later, very tired 3 hours after dose till the next morning, shortness of breath/heart felt like it was beating fast for a few minutes started about 5 hours after vaccine and stopped the next day around 6pm.
Pt became pale, light headed and nauseas after administration. Event reported to Provider - B/P and finger glucose obtained. After lying down for aprrox 5-10 mionutes, S/s disapeared and Pt stated that she felt fine. No treatment given
6 hours after vaccination, I became fatigued and chilled. 18 hours after vaccination, I was nauseous and faint. I also experienced diarrhea. Symptoms lasted for 3 days.
Initial report received on 30 July 2012 from the Investigator participating in the post-marketing observational surveillance study under the reference number M5A16. A case of pertussis disease in a 3-year-old female subject (initials not collected) was identified by the investigator based on review of data from the Electronic Disease Surveillance electronic database. The subject had received a first dose of TRIPEDIA, lot number U2397BA on 06 October 2008; a second and third dose of PENTACEL, lot number C2881AA on 19 December 2008 and 17 February 2009; and a dose of DAPTACEL, lot number C3191AA on 08 February 2010 (routes and sites administration not reported). The subject developed a cough on 02 July 2012, approximately 28 months after the last dose. On 11 July 2012, the subject developed a paroxysmal cough without a whoop. The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included positive PCR on 18 July 2012. Chest x-ray findings were negative for pneumonia. Corrective treatment consisted of Azithromycin starting on 19 July 2012 for 5 days. The subject was not hospitalized. At the time of final contact on 23 July 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 21 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Cant focus her eyes; Blurry vision; This spontaneous case was reported by a consumer and describes the occurrence of REFRACTION DISORDER (Cant focus her eyes) and VISION BLURRED (Blurry vision) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 044B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced REFRACTION DISORDER (Cant focus her eyes) and VISION BLURRED (Blurry vision). At the time of the report, REFRACTION DISORDER (Cant focus her eyes) and VISION BLURRED (Blurry vision) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable Other concomitant medications reported were Vitamins No treatment reported.